Clinical OMICS

MAY-JUN 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/979295

Contents of this Issue

Navigation

Page 6 of 51

HTG Molecular Diagnostics, Inc. 3430 E. Global Loop, Tucson, AZ 85706 Call 877-289-2615 For Research Use Only. Not for use in diagnostic procedures. In the U.S. and other applicable jurisdictions, HTG EdgeSeq is a trademark of HTG Molecular Diagnostics, Inc. Any other trademarks or trade names used herein are the intellectual property of their respective owners. Partnerships: personalized HTG and QIAGEN partner to advance CDx solutions. HTG is a comprehensive, NGS-based molecular profiling company that enables your success in biomarker discovery and drug development. HTG is a committed partner every step of the way: from translational research through clinical development and commercial deployment. To further our commitment for your success, HTG and QIAGEN have a Precision Diagnostic Partnership (PDP) to offer pharmaceutical companies a complete NGS-based solution for the development and commercialization of companion diagnostics. To learn more about our partnership's ability to accelerate CDx programs, visit www.htgmolecular.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAY-JUN 2018